Oncology & Cancer

Narrowing the gap toward precision medicine for pancreatic cancer

University of North Carolina Lineberger Comprehensive Cancer Center's Jen Jen Yeh, MD, is working to understand the complicated relationship between one of the deadliest cancers and the web of connective tissue that can surround ...

Oncology & Cancer

New insights on the addictions of tumors

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego have shown that tumors can ensure a more reliable nutrient supply by eliminating the p62 protein in surrounding stromal tissue. Specifically, ...

Oncology & Cancer

A one-two punch hits pancreatic cancer where it hurts

Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it 'softer' and more responsive to chemotherapy. The findings are published today ...

Medical research

Scientists wage fight against aging bone marrow stem cell niche

As people get older so do the hematopoietic stem cells (HSCs) that form their blood, creating an increased risk for compromised immunity and certain blood cancers. Now researchers are reporting in the scientific journal EMBO ...

Oncology & Cancer

New analysis methodology may revolutionize breast cancer therapy

Stroma cells are derived from connective tissue and may critically influence tumour growth. This knowledge is not new. However, bioanalyst Christopher Gerner and an interdisciplinary team from the University of Vienna and ...

Oncology & Cancer

Now we know why drugs don't work on pancreatic cancer

The trouble with treating cancer is that each type has its own quirks. The quirks of pancreatic cancer make it one of the most lethal. The survival period after diagnosis is only four to six months. The main reason is that ...

page 2 from 3